XPhyto Completes Rotigotine Transdermal Patch Optimization and Comparative Skin Absorption Study
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / October 11, 2022 /XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide a product developm…